PATENT CLAIM ANALYSIS

Application Number: 16087318
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["514", "260100"]

Abstract:
The invention relates to a salt form of (R)-methyl-2-(3-aminopiperidin-1-yl)-3-(2-cyanobenzyl)-4-carbonyl-3,4-dihydrothiophene[3,2-d]pyrimidine-6-carboxylic acid and a preparation method for the salt form. Also disclosed is a pharmaceutical composition of the formula I compound salt form. The salt form of the invention provides powerful in vivo hypoglycemic activity and is expected to be a novel pharmaceutical active ingredient for treating or preventing diabetes mellitus type 2 and/or complications of diabetes mellitus type 2

Claim (Index 1):
A salt form of a compound of formula I, characterized in that the salt form is selected from the group consisting of hydrochloride, maleate, phosphate and glycolate

Metadata:
- Claim Count in Document: 20.0
- Percentile: 97.0
- Lexical Diversity: 1.54545
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16087317', '16316055', '13522549', '14698463', '15746966']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7751118810626823
- 35 USC 102 Novelty (BERT): 0.5266582287714834
- Combined Prediction Score: 0.7502665158335624
- Mean Citation Score: 261.05123
- Max Citation Score: 316.59814
- Similarity Product: 219.43080411645167

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test